Correspondence 0001104659-25-006681 from PSYENCE BIOMEDICAL LTD. (PBM)
PSYENCE BIOMEDICAL LTD.
Date: Jan. 28, 2025 · CIK: 0001985062 · Accession: 0001104659-25-006681
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-284444
Letter
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
January 28, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re: Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed January 24, 2025|
File No. 333-284444
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced Registration Statement so that it will become effective at 4:30 p.m. Eastern Time on Thursday, January 30, 2025, or as soon as thereafter practicable.
Very truly yours,
PSYENCE BIOMEDICAL LTD.
Show Raw Text
CORRESP
1
filename1.htm
Psyence Biomedical Ltd.
121 Richmond Street West
Penthouse Suite 1300
Toronto, Ontario M5H 2K1
January 28, 2025
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporate Finance
Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549
Re:
Psyence Biomedical Ltd.
Registration Statement on Form F-1
Filed January 24, 2025|
File No. 333-284444
Ladies and Gentlemen:
Pursuant to Rule 461 under
the Securities Act of 1933, as amended, Psyence Biomedical Ltd. hereby requests acceleration of effectiveness of the above referenced
Registration Statement so that it will become effective at 4:30 p.m. Eastern Time on Thursday, January 30, 2025, or as soon as thereafter
practicable.
Very truly yours,
PSYENCE BIOMEDICAL LTD.
By:
/s/ Neil Maresky
Neil Maresky